The requirements for CTL-mediated rejection of cancer in humans

NKG2D and its role in the immune responsiveness of melanoma

Ena Wang, Silvia Selleri, Francesco M. Marincola

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)7228-7231
Number of pages4
JournalClinical Cancer Research
Volume13
Issue number24
DOIs
Publication statusPublished - 15 Dec 2007
Externally publishedYes

Fingerprint

Immunologic Receptors
Tumor Escape
Tumor-Infiltrating Lymphocytes
Cytotoxic T-Lymphocytes
Tumor Biomarkers
Lymphocyte Activation
Cell Differentiation
Melanoma
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The requirements for CTL-mediated rejection of cancer in humans : NKG2D and its role in the immune responsiveness of melanoma. / Wang, Ena; Selleri, Silvia; Marincola, Francesco M.

In: Clinical Cancer Research, Vol. 13, No. 24, 15.12.2007, p. 7228-7231.

Research output: Contribution to journalArticle

@article{8049610710f54d668c6441144eaab195,
title = "The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma",
author = "Ena Wang and Silvia Selleri and Marincola, {Francesco M.}",
year = "2007",
month = "12",
day = "15",
doi = "10.1158/1078-0432.CCR-07-2150",
language = "English",
volume = "13",
pages = "7228--7231",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "24",

}

TY - JOUR

T1 - The requirements for CTL-mediated rejection of cancer in humans

T2 - NKG2D and its role in the immune responsiveness of melanoma

AU - Wang, Ena

AU - Selleri, Silvia

AU - Marincola, Francesco M.

PY - 2007/12/15

Y1 - 2007/12/15

UR - http://www.scopus.com/inward/record.url?scp=37549046415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549046415&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-2150

DO - 10.1158/1078-0432.CCR-07-2150

M3 - Article

VL - 13

SP - 7228

EP - 7231

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 24

ER -